Thus, deletion of metE predominantly attenuates Mtb in anemic mice
Lancet 2017;390:26272642 [DOI] [PMC free article] [PubMed] [Google Scholar] 88
The gentle ramp from 0.25 mg up to 2.4 mg mirrors the phase 2 dose-finding schedule that achieved meaningful weight loss while keeping nausea and other gastrointestinal effects manageable [1] [4]
According to a 2024 article by the Columbia University Department of Psychiatry, semaglutides 2021 FDA approval came with wide recognition for its medical benefits and its notable side effect of weight loss. What resulted from that was a surge in its off-label use as a weight-loss aid, propelling the drug into the spotlight far beyond its original intent. Then, also in 2021, the FDA approved Wegovy for individuals who are obese or overweight with additional health challenges. Columbia University also notes the ethical concerns of drugs like Ozempic and Wegovy, particularly in their pricing
With high purity, excellent stability, and outstanding formulation compatibility, it is suitable for capsules, tablets, powders, gummies, sachets, functional beverages, and cosmetic formulations
